Detecting Thrombophilia, Hypofibrinolysis and Reduced Nitric Oxide Production in Osteonecrosis
Gene mutations leading to thrombophilia, hypofibrinolysis, and reduced nitric oxide production are risk factors for osteonecrosis. The importance of the diagnosis of thrombophilia–hypofibrinolysis in idiopathic osteonecrosis lies in the potential to stop the progression of osteonecrosis when enoxaparin is started at Ficat stages I or II before irreversible segmental collapse of the head of the femur.
Keywords: thrombophilia, hypofibrinolysis, osteonecrosis, reduced nitric oxide production
To access this article, please choose from the options below
One or more of the authors (CJG) has received funding from the Jewish Hospital Medical Research Council. None of the authors has any conflicts of interest.The Jewish Hospital Institutional Review Board approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research, and that informed consent was obtained.
PII: S1045-4527(07)00039-9
doi:10.1053/j.sart.2007.06.005
© 2007 Elsevier Inc. All rights reserved.
